Table 3.
Species | Behavioral task | Histaminergic modulator | Lesion or pharmacological induced memory impairment | Effect on memory | Reference(s) |
---|---|---|---|---|---|
Rat | Passive avoidance | Histamine | ↑ | [120, 121] | |
Rat | Passive avoidance | Histamine | ↓ | [122–124] | |
Mouse | Passive avoidance | Histamine | Lithium (i.p.) | ↑ | [125] |
Rat | Active avoidance | Histamine | ↑ | [126] | |
Rat | Active avoidance | Histamine | ↓ | [127] | |
Rat | Active avoidance | Histamine | Bilateral hippocampectomy (dorsal hippocampus) | ↑ | [128] |
Rat | Active avoidance | Histamine | alpha-FMH (i.p.) | ↑ | [126] |
Rat | Habituation in open field | Histamine | ↑ | [121] | |
Rat | Social memory | Histamine | ↑ | [129] | |
Rat | Social memory | Histidine | ↑ | [129] | |
Rat | Social memory | alpha-FMH | ↓ | [129] | |
Rat | Radial maze | Histamine | N-methyl- d-aspartate (NMDA) receptor glycine site antagonist (7-chlorokynurenic acid) i.c.v | ↑ | [130] |
Rat | Radial maze | alpha-FMH | ↓ | [131] | |
Rat | Passive avoidance | H1 receptor antagonist (chlorpheniramine) | ↑ | [122] | |
Rat | Passive avoidance | H1 receptor antagonist (pyrilamine ) | ↑ | [124] | |
Rat | Passive avoidance | H2 receptor antagonist (cimetidine) | ↑ | [123, 124] | |
Mouse | Passive avoidance | H2 receptor agonist (4-methylhistamine) | ↓ | [90] | |
Rat | Active avoidance | H1 receptor agonist (2-methylhistamine and 2-thiazolylethylamine) | ↓ | [127] | |
Rat | Step-through active avoidance | H1 receptor agonist (2-methylhistamine) | ↑ | [132] | |
Rat | Step-through active avoidance | H1 receptor antagonist (pyrilamine or diphenhydramine) | ↓ | [132] | |
Rat | Social memory | H3 receptor agonist (immepip) | ↓ | [129] | |
Rat | Social memory | H3 receptor antagonist (thioperamide) | ↑ | [129] | |
Rat | Object recognition | H1 receptor agonist [2-(3-(trifluoromethyl)-phenyl)histamine] | ↑ | [133] | |
Rat | Water maze | H1 receptor antagonist (chlorpheniramine) | ↑ | [134] |
alpha-FMH: alpha-fluoromethylhistidine (inhibitor of histamine decarboxylase)
i.p. intraperitoneal
i.c.v intracerebroventricular.